Ignite Creation Date:
2024-05-06 @ 8:08 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06265220
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-02-09
Brief Title:
AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus
Sponsor:
Organization:
Artiva Biotherapeutics Inc